Vitrolife: Increased Sales Potential - Regulatory Approval in Japan for Aspiration Needles Opens the Second Largest IVF Market

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR) has obtained regulatory approval for the sale of aspiration needles and micro pipettes which are used in infertility treatment (IVF). This means that another important market in Asia can be processed with a higher offer and the total sales potential increases.

MORE ON THIS TOPIC